In this review, we will first briefly describe the diverse molecular mechanisms associated with PTEN loss of function in cancer. We will then proceed to discuss the molecular mechanisms linking PTEN loss to PI3K activation and demonstrate how these mechanisms suggest possible therapeutic approaches for patients with PTEN-null tumors.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921025 | PMC |
http://dx.doi.org/10.3390/biom9110713 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!